· First, summarize the article attached titled: Prenatal Exposure to Progesterone Affects Sexual Orientation in Humans and describe the biological basis of sexual orientation, including the brain regions, neurotransmitters, and hormones that may be associated with sexual orientation. Also consider any developmental factors that may influence later sexual orientation. Include any relevant anatomical or physiological markers that seem to be associated with a particular sexual orientation.
· Summarize your article on the biological basis of sexual orientation in enough detail that your reader will understand what was done in the study and what the results of the study.
· Finally, develop and describe a high-level overview of an educational program about the biological basis of sexual orientation. This should be appropriate to present to a middle school biology class. What would you include in this educational program? What would you not include in the educational program? How would you convey the ideas you have described in this week’s Assignment in a way that would not offend your audience, but would also minimize the giggles of young teenagers?
*** The article attached must be used, please cite from the article attached and other sources!***
Running head: ACADEMIC CLINICAL SOAP NOTE 1
PAGE
2
ACADEMIC CLINICAL SOAP NOTE
Academic Clinical Soap Note
SUBJECTIVE
Chief Complaint:
Patient is in clinic today for second peptide receptor radionuclide treatment (PRRT) with Lutathera treatment.
Background:
This is a pleasant 47-year-old female with a history of metastatic pancreatic neuroendocrine tumor. She was initially diagnosed in October 2016 presenting with pneumonia with an incidental lung nodule noted. Biopsy demonstrated low-grade neuroendocrine of 1%. She then was noted to have metastatic disease in the right breast biopsy proven in February 2017. Somatostatin analog therapy was initiated then. When the patient progressed in September 2017 she was transitioned to Afinitor. A right thyroid nodule was noted and biopsied in December 2018 with benign findings. That due to Tait scan in January 2019 showed progression of disease. She was transitioned to Capoten for one cycle with recurrence of pancreatitis as well as development of splenic vein thrombus in February 2019. She had persistent pancreatitis in March 2019 on CT imaging. After, GI tumor board review at Stony Brook University Hospital she was found to be metastatic low-grade neuroendocrine tumor more likely pancreatic origin. Because of persistent abdominal pain she underwent celiac plexus block in May 2019. She was subsequently referred for peptide receptor radionuclide therapy/ Lutathera and received first dose on 7/17/2019. She has recently moved to Florida 3 weeks ago and presents to reestablish for continuation of Lutathera treatment at Moffitt Cancer Center.
Family History:
Father died of prostate cancer in 1998. Mother had diabetes, heart disease, and hypertension, she passed in 2010. Patient state she had several uncles that died from cancer, but she does not recall which cancer they had.
Medication:
· Insulin (Lantus) glargine 20 unit(s), SubQ, DAILY.
· fluticasone nasal (Flonase 50 mcg/inh nasal spray) 2 spray(s), NASAL, DAILY.
· pancrelipase 6000 units oral delayed release capsule, PO, QID.
· Simvastatin 10 mg, 1 tab(s), PO, Bedtime
· Metoprolol 50 mg, 1 tab(s), PO, Daily
· NIFEdipine 30 mg, 1 tab(s), PO, Daily
· Losartan (losartan 100 mg oral tablet) 100 mg, 1 tab(s), PO, AS NEEDED.
· Multivitamin (Multi Vitamin+) PO, DAILY
· Vitamin C lozenge 500 mg, 1 tab(s), PO, Daily
· Multivitamin with iron (Iron 100 Plus) PO, DAILY.
· Multivitamin (Vitamin B Complex oral capsule) 1 cap(s), PO, Daily
· Biotin (biotin 5000 mcg oral tablet, disintegrating) PO, DAILY
Review of Systems:
Constitutional: She has a long-term history of fatigue. Weight loss of 30lb since beginning of 2019. No fever, no chills, no weakness, no decrease activity.
Eye: No recent visual problem, No double vision.
Ear/Nose/Mouth/Throat: No dry mouth, No nasal congestion, No mouth sores, No mucositis.
Respiratory: No shortness of breath, No cough, No sputum production.
Cardiovascular: No palpitations, No bradycardia, No tachycardia.
Breast: No nipple discharge.
Gastrointestinal: Occasionally nausea with no vomiting. She has constipation alternating with diarrhea. Stomach pain 4 on scale 0-10. Last bowel movement today.
Genitourinary: No dysuria, No hematuria.
Gynecologic: Negative.
Hematological/Lymphatics: No bruising tendency, No bleeding tendency.
Endocrine: No cold intolerance, No heat intolerance.
Immunologic: No recurrent fevers, No recurrent infections.
Musculoskeletal: No claudication.
Integumentary: No rash.
Neurologic: Alert and oriented X4.
Psychiatric: Not delusional, No hallucinations.
OBJECTIVE
Vital Signs:
Temperature: 98.65 Heart Rate: 74, Blood Pressure: 112/74, Respiratory Rate: 14, SpO2: 100%, Weight: 57.3kg, Height: 5 ft 6 in and BMI: 21.1
Physical Examination:
General: Compared weight chart and noted a 30lb weight loss. Alert and oriented, No acute distress.
HEENT: Oropharynx clear, Normocephalic, Oral mucosa is moist.
Cardiovascular: Normal rate, Good pulses equal in all extremities.
Respiratory: Lungs are clear to auscultation, Symmetrical chest wall expansion.
Gastrointestinal: Pain elected on lite palpation soft. Non-tender, Non-distended. Hematological/Lymphatics: Lymphatic exam: Right, Submandibular, 10 mm ( By 10 mm ). Extremities: Normal range of motion, No deformity, Normal gait.
Integumentary: Warm, Intact.
Neurologic: Normal sensory, No focal defects.
Cognition and Speech: Speech clear and coherent, Functional cognition intact.
Psychiatric: Cooperative, Appropriate mood & affect
Labs/Imaging/ Diagnostic Test Result:
Abnormal Labs: Glucose- 219 H: Mean Cell Volume: 94.2 H: RDW: 52.7 H:
Diagnostic Data: Detailed review of the PET/CT: demonstrates numerous metastatic avid lesions within the soft tissues and osseous structures involving bilateral breasts, liver, pancreas, metastatic lesion in the left peritoneum and irregular mass in the left pelvis and persistent multiple osseous metastasis.
ASSESSMENT/CLINICAL IMPRESSIONS
Health Problems:
1. Neuroendocrine Tumor D3A.8
2. Pancreatitis K85
3. Diabetes E23.2
4. Hyperlipidemia E78.49
Differential Diagnosis:
ICD-10 K29: Zollinger-Ellison Syndrome- is characterized by gastric acid hypersecretion resulting in severe acid-related peptic disease and diarrhea. The tumors are thought to emerge from the delta cells that are found in the pancreas and it was founded to account for about 25% to 40% of gastrinomas. The rest of the endocrine tumors to include the 50- 70% of abnormal cells were found in the small digestive tract, while about 5% emerge from other intra-stomach area. “Gastric not only directly stimulates parietal cell secretion but also causes expansion of the mass of parietal cells. The increase in parietal cells results in an increase in basal acid output and maximal acid output. This substantial secretion of acid results in gastroesophageal reflux disease (GERD) symptoms and damage to the mucosal lining of the GI tract, causing peptic ulcers. In addition, the acid inactivates pancreatic enzymes, which contributes to the diarrhea, steatorrhea, and malabsorption of lipid-soluble nutrients (www.epocrate.com.2019).”
ICD-10 E34.0: Carcinoid Syndrome- progress in some people with carcinoid tumors and is identified by cutaneous flushing, abdominal cramps, and diarrhea. There are a number of symptoms relevant to CS that healthcare work looks for such as the abnormal labs are the first to investigate then there are the physical manifestations. Carcinoid syndrome is seen in individuals who have an underlying carcinoid tumor that has spread to the liver. Carcinoid syndrome is a rare condition that effect about 10% of the population. “Carcinoid syndrome may be more prevalent than suspected because diagnosis is difficult and sometimes overlooked; some patients may not exhibit all three of the hallmark symptoms of flushing, wheezing, and diarrhea (www.raredisease.org. 2019).”
ICD-10 D35.00: Pheochromocytoma- Is the type of “tumor arising from catecholamine-producing chromaffin cells of the adrenal medulla that classically presents with headaches, diaphoresis, and palpitations in the setting of paroxysmal hypertension (www.epocrate.com 2019).” This disease secrete adrenaline in an uncontrolled manner and can cause severe medical issues including heart disease, stroke, and ultimate this can lead to death.
PLAN COMPONENT MANAGEMENT:
Research has shown that there are few neuroendocrine tumors that may not have a clear primary tumor site and these tumors will be treated based on the histology. Many neuroendocrine tumors tend to poorly differentiated and may grow and spread rapidly. In order to get a better understanding of the tumor dynamic imaging studies a long with scopes to see the internal area of the tumor body will be utilized by the provider. EUS and biopsy may be done to confirm the cell type. The initially diagnostic test can start with the CT of the chest, abdomen, and/ or pelvis, MRI, FDG_PET/ CT scan, and biochemical testing. The patient that has a poorly differential neuroendocrine tumor the treatment option ideally utilizes a combination of options. The doctor will decide which treatment will work best, for the patient at that time; “one treatment option is the surgical option this will include resection + adjuvant chemotherapy +/- radiation therapy. There is locoregional surgical option that involves radiation therapy and chemotherapy given at the same time or one treatment after the other or just chemotherapy only. If the neuroendocrine tumor is metastatic than the treatment option is chemotherapy and every three months the patient will come into the clinic and have his/ her lab drawn and CT or MRI completed to check the progression of the treatment and at the time the provider and patient will decide based on the diagnostic report how to proceed (www.nccn.org. 2019).”
Providers at the Moffitt cancer center have used peptide receptor radionuclide therapy (PRRT) with great success. “The FDA approval of Lutathera, a peptide receptor radionuclide therapy (PRRT), on January 26, 2018, for a new era in treatment options for the neuroendocrine tumor (www.newRx.org. 2016).” When PRRT is use it was found to manifest long term effectiveness to the treatment of neuroendocrine tumor while also allowing the patient to maintain a high-quality lifestyle. The patient can use PRRT repeatedly with very little side effects and rarely these patients were dialysis dependent.
“All PRRT candidates must first be seen by an Oncologist in order to be evaluated for treatment. The requests for PRRT treatment should be for a GI oncology consult (De Visser, M., 2008).” Cost associated with the PRRT can be costly but patient who do not have insurance, Medicare/ Medicaid there are programs that can help with getting qualified for therapy. The PRRT drug can be offered free to the patient that do not have insurance but there will be costs for medications to help with the side effect of PRRT such as nausea and vomiting, and there will be costs to the institution and medical personnel providing the service.
Disposition/ Discharge Plan:
“Peptide Receptor Radionuclide Therapy uses radiation to kill cancer cells, this mean that this medication works differently than other cancer drugs. PRRT is given in a hospital setting and have two components to the therapy (Thang. S. P., et.al 2018).” There is the tumor targeted part that finds the cancer cell with a receptor called somatostatin. Then there is the radioactive component that actually kills the cancer cell. This cancer infusion is given up to four times and eight weeks apart from each infusion. Once the infusion has completed the patient will be given an injection of long acting octreotide to decrease the cancer from growing or spreading. The patient will be given anti-nausea medication, amino acid hydration solution medication, and then 45 minutes later the patient will receive the PRRT treatment.
The nurse will explain during the discharge planning that it is imperative that the patient must drink a lot of fluids/ water and urinate frequently before, during and after treatment because this will help the radiation to leave the body. Patient should also limit close contact with pregnant women, children, and immune compromised patient for the first two weeks after therapy to prevent exposure and the patient must practice good hand hygiene with soap and water often. Expected outcome of PRRT is to “reduce the risk of cancer spreading, growing, or getting worse by 79% compared to a larger than normal dose of long-acting octreotide (www.carcinoid.org. 2019).”
Health Education/ Promotion and Disease Prevention:
Patient education/ health promotion include “minimize radiation exposure during and after treatment with PRRT-consistent with institutional good radiation safety practices and patient management procedures, monitor blood cell counts because of myelosuppression; treatment may be placed on hold, dose educed, or permanently discontinue PRRT treatment based on negative reaction to treatment, hepatotoxicity can cause a decrease in blood levers therefore monitor transaminases, bilirubin and albumin. Due to neuroendocrine hormonal crisis patient must be monitored for flushing, diarrhea, hypotension, bronchoconstriction or other signs and symptoms, embryo-fetal toxicity can occur with PRRT in which the fetal harm can come about. Advise females and males of reproductive potential of the potential risk to a fetus and to use effective contraception and PRRT can cause infertility (www.carcinoid.org. 2019).” Patient are also instructed to make sure they continue to update their medication list to prevent adverse reaction. Disease prevention focus is on consuming half the patient body weight in water daily, eating a healthy diet that consist of fresh fruit and vegetable, avoid white pasta and rice, organic meats, fruits, and vegetables is considered a better choice (think rainbow colors when it comes to healthy eating). Maintaining a healthy weight and BMI. Patient are instructed to work out 150 minutes per week about 3 to 4 times in that week, stress reduction is another prevention option, and finally getting enough rest so that the body can fight off the cancer cell that is circulating in the body.
References
Carcinoid Syndrome. (2019). Retrieved from https://rarediseases.org/rare-diseases/carcinoid-syndrome/
de Visser, M., Verwijnen, S. M., & de Jong, M. (2008). Update: Improvement strategies for peptide receptor scintigraphy and radionuclide therapy. Cancer Biotherapy & Radiopharmaceuticals, 23(2), 137-57. doi:http://dx.doi.org.lopes.idm.oclc.org/10.1089/cbr.2007.0435
Neuroendocrine cancer; long-term experience supports efficacy and safety of PRRT for treating neuroendocrine tumors. (2016, Nov 06). NewsRx Health Retrieved from https://lopes.idm.oclc.org/login?url=https://search-proquest-com.lopes.idm.oclc.org/docview/1832797816?accountid=7374
Pheochromocytoma. (2019). Retrieved from https://online.epocrates.com/diseases/16332/Pheochromocytoma/Risk-Factors
Thang, S. P., Mei, S. L., Kong, G., Hofman, M. S., Callahan, J., Michael, M., & Hicks, R. J. (2018). Peptide receptor radionuclide therapy (PRRT) in european neuroendocrine tumour society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis. European Journal of Nuclear Medicine and Molecular Imaging, 45(2), 262-277. doi:http://dx.doi.org.lopes.idm.oclc.org/10.1007/s00259-017-3821-2
Treatment Guideline: Neuroendocrine Tumors. (2019). Retrieved from https://www.nccn.org/patients/guidelines/neuroendocrine/88/
What is LUTATHERA®? (2019). Retrieved from https://www.carcinoid.org/wp-content/uploads/2018/07/AAA_Lu177_US_0058_LUTATHERA_lutetitum_Lu177_dotatate_Patient_Fact-Sheet_Final-July-2018.pdf
Zollinger-Ellison syndrome. (2019). Retrieved from https://online.epocrates.com/diseases/40824/Zollinger-Ellison-syndrome/Etiology27, 2018, from https://www.atsjournals.org/doi/citedby/10.1513/pats.200604-099SS
Rubic_Print_Format
Course Code | Class Code | Assignment Title | Total Points |
ANP-650 | ANP-650-XO0103XB | Academic Clinical SOAP Note | 65.0 |
Criteria | Percentage | Excellent (100.00%) | |
Content | 70.0% | ||
Primary or Working Diagnosis | 10.0% | A one-sentence description of the primary working diagnosis, pending differential diagnoses, and context or service in which the patient is being seen is provided and includes supporting details. | |
Brief Clinical Course | 10.0% | A one-to-two paragraph description of the current illness or hospital stay, including pertinent diagnostic findings or procedures and the number of days since the patient has been hospitalized, is complete with supporting documentation. | |
Review Of Systems | 10.0% | Five systems affected by the working diagnosis, along with two positive or negative effects of the diagnosis on each system, are provided with thorough details and support. | |
Exam | 10.0% | Five systems examined within the last 24 hours, including two positive or negative findings relevant to each system and a full set of vital signs, are provided with thorough details and support. | |
Diagnostics | 10.0% | Admission diagnostics are provided with thorough details and support. | |
Impression or Assessment | 10.0% | Identification of all acute and chronic diagnoses in order of ICD-10 priority and any differential diagnoses being eliminated are provided with thorough details and support. | |
Plan | 5.0% | A treatment plan that corresponds with the diagnosis and includes admission type, diagnostics, medications and dosages, and any consults or follow-up procedures needed is provided with thorough details and support. | |
Geriatric Specific Care | 5.0% | A discussion of ethical, legal, or geriatric considerations is provided with thorough details and support. | |
Organization and Effectiveness | 10.0% | ||
Mechanics of Writing (includes spelling, punctuation, grammar, language use) | 10.0% | Writer is clearly in command of standard, written, academic English. | |
Format | 20.0% | ||
Paper Format (Use of appropriate style for the major and assignment) | 10.0% | All format elements are correct. | |
Documentation of Sources (citations, footnotes, references, bibliography, etc., as appropriate to assignment and style) | 10.0% | Sources are completely and correctly documented, as appropriate to assignment and style, and format is free of error. | |
Total Weightage | 100% |
Academic Clinical SOAP Note
Academic clinical SOAP notes provide a unique opportunity to practice and demonstrate advanced practice documentation skills, to develop and demonstrate critical thinking and clinical reasoning skills, and to practice identifying acute and chronic problems and formulating evidence-based plans of care.
Develop a hospital follow-up progress SOAP note based on a clinical patient from your practicum setting. In your assessment, provide the following:
· A one-sentence description of the primary working diagnosis, pending differential diagnoses, and the context or service in which the patient is being seen.( Acute Care Hospital)
· A one-to-two paragraph description of the current illness or hospital stay, including pertinent diagnostic findings or procedures. Include how many days the patient has been hospitalized, if applicable.
· List of at least five systems affected by the working diagnosis. Provide two positive or negative effects that the working diagnosis has on each system.
· List of at least five systems examined within the last 24 hours. Provide at least two pertinent positive or negative findings relevant to each system examined and include a full set of vital signs.
· List of all pertinent acute and chronic diagnoses in order of priority using ICD-10. Identify any differential diagnoses being eliminated.
· Treatment plan that corresponds with the diagnosis. Provide information on admission type, types of diagnostics, any prescribed medications and dosages, and any relevant consults or follow-up procedures needed.
· Discussion of any relevant ethical, legal, or geriatric-specific considerations.
Incorporate at least 3-5 peer-reviewed articles in the assessment or plan. (Minimum 1200 words).
Don’t Forget to include all coding including ICD-10, CPT and all others.
While APA style is not required for the body of this assignment, solid academic writing is expected, and documentation of sources should be presented using APA formatting guidelines, which can be found in the APA Style Guide, located in the Student Success Center.
This assignment uses a rubric. Please review the rubric prior to beginning the assignment to become familiar with the expectations for successful completion.
You are required to submit this assignment to LopesWrite. Refer to the LopesWrite Technical Support articles for assistance.
ORIGINAL PAPER
Prenatal Exposure to Progesterone Affects Sexual Orientation in Humans
JuneM. Reinisch1,2,3 • Erik Lykke Mortensen3,4 • Stephanie A. Sanders1,5
Received: 18 June 2013 / Revised: 15 December 2016 /Accepted: 15 December 2016 / Published online: 3 April 2017
� Springer Science+Business Media New York 2017
Abstract Prenatal sexhormone levelsaffectphysicalandbehav-
ioralsexualdifferentiationinanimalsandhumans.Althoughprena-
tal hormones are theorized to influence sexual orientation in
humans, evidence is sparse. Sexual orientationvariables for 34
prenatally progesterone-exposed subjects (17 males and 17
females) were compared to matched controls (M age= 23.2
years). A case–control double-blind design was used drawing
on existing data from the US/Denmark Prenatal Development
Project. Index cases were exposed to lutocyclin (bioidentical
progesterone=C21H30O2;MW:314.46)andnootherhormonal
preparation. Controls were matched on 14 physical, medical,
and socioeconomic variables. A structured interview conduc-
ted by a psychologist and self-administered questionnaires
were used to collect data on sexual orientation, self-identifi-
cation,attractiontothesameandothersex,andhistoryofsexual
behavior with each sex. Compared to the unexposed, fewer
exposedmalesandfemales identifiedasheterosexualandmore
of them reported histories of same-sex sexual behavior, attrac-
tiontothesameorbothsexes,andscoredhigheronattractionto
males.Measuresofheterosexualbehaviorandscoresonattrac-
tiontofemalesdidnotdiffersignificantlybyexposure.Wecon-
clude that, regardless of sex, exposure appeared to be associ-
atedwithhigherratesofbisexuality.Prenatalprogesteronemaybe
an underappreciated epigenetic factor in human sexual and psy-
chosexual development and, in light of the current prevalence of
progesterone treatment during pregnancy for a variety of preg-
nancy complications, warrants further investigation. These data
ontheeffectsofprenatalexposuretoexogenousprogesteronealso
suggest a potential role for natural early perturbations in proges-
terone levels in the development of sexual orientation.
Keywords Sexual orientation � Prenatal progesterone exposure � Bisexuality � Sexual behavior
Introduction
Although prenatal gonadal hormones have been theorized to
influence sexual orientation in humans, other than recent
research using a surrogate measure (2D:4D digit ratio) for pre-
natalandrogenexposure(Hiraichi,Sasaki,Shikishima,&Ando,
2012; Wong & Hines, 2015), evidence from studies of exoge-
noushormoneexposure is sparse (Adkins-Regan, 1988;Ellis&
Ames, 1987; Gooren, 2006; Hines, 2011; Hines, Constanti-
nescu, & Spencer, 2015; Meyer-Bahlburg, 1984). Despite rel-
atively frequent current administration of exogenous proges-
terone to pregnant womenwith a variety of clinical problems,
even less attention has been paid to the possible role of prenatal
exposure to progesterone on any aspect of human sexual and
psychosexual development (Kester, Green, Finch,&Williams,
1980; Reinisch, Ziemba-Davis, & Sanders, 1991; Sanders &
Reinisch, 1985; Wagner, 2008). Perhaps this is due to the ele-
vated levels of natural progesterone present during gestation lead-
ing to the assumption that additional exogenous doses would not
affect these aspects of development.
& June M. Reinisch [email protected]
1 The Kinsey Institute for Research in Sex, Gender and
Reproduction, Indiana University, Morrison Hall 313,
Bloomington, IN 47405, USA
2 The Museum of Sex, New York, NY, USA
3 Institute of Preventive Medicine, Copenhagen University
Hospital, Copenhagen, Denmark
4 Department of Public Health, University of Copenhagen,
Copenhagen, Denmark
5 Department of Gender Studies, Indiana University,
Bloomington, IN, USA
123
Arch Sex Behav (2017) 46:1239–1249
DOI 10.1007/s10508-016-0923-z
The prenatal hormone or neuroandrogenic theory of sexual
orientation (Ellis & Ames, 1987; Gooren, 2006; Hines, 2010;
Meyer-Bahlburg, 1984) assumes that heterosexuality is an in-
herent part of ‘‘normal’’ sexual differentiation and that homo-
sexuality (as evidenced by self-identification, same-sex sexual
behavior, or attraction/desire) is a result of perturbations in the
typical prenatal hormone environment. Specifically, the theory
suggests that homosexuality is the result of insufficient prenatal
androgenexposureoraction inmalesandexcessprenatalandro-
gen exposure in females during sensitive periods of early devel-
opment.Thus,homosexuality isviewedassomedegreeof femi-
nization and/or demasculinization of males and of masculin-
izationand/ordefeminizationof females.Bisexuality inhumans
isoften thoughtofas‘‘partialhomosexuality’’orasmovingaway
from‘‘exclusive heterosexuality’’toward amiddle point along a
bipolar unidimensional continuum between exclusive hetero-
sexuality and exclusive homosexuality (Kinsey, Pomeroy, &
Martin, 1948).ThisbipolarKinseyscalemodel implies a trade--
off betweenheterosexuality andhomosexuality—themorehomo-
sexual, the lessheterosexual (seeSanders,Reinisch,&McWhirter,
1990).
For ethical reasons, support for the formative role of prenatal
sex hormones in the development of sexual orientation is based
primarily on experiments with animals (Adkins-Regan, 1988;
Balthazart, 2011; Hines, 2011; Meyer-Bahlburg, 1984), a few
clinical studies of humans whose prenatal hormone environ-
ments were altered bymetabolic anomalies (Cohen-Bendahan,
van de Beek, & Berenbaum, 2005; Hines, 2004, 2010, 2011;
Jordan-Young,2012;Meyer-Bahlburg, 1984), ormaternalmedi-
cal treatment with estrogenic compounds during gestation
(Meyer-Bahlburgetal.,1995),andmostrecentlythestudiesusing
digit ratio measures to reflect the prenatal gonadal hormone
environment (Grimbos,Dawood,Burris,Zucker,&Puts,2010;
Wong&Hines, 2015). Critiques (Adkins-Regan, 1988; Balt-
hazart,2011;Hines,2011;Meyer-Bahlburg,1984;Valla&Ceci,
2011) of this perspective and its putative supportive animal
research include: (1) conflation of heterotypic sexual behavior in
animals (i.e., acceptingmounts inmalesormountingby females)
andhumanhomosexuality (e.g., themale ratwhomounts another
maleisnotconsidered‘‘homosexual,’’whilethemountedmaleis);
(2) limitations in extrapolating from phylogenetically distant ani-
mals to humans; and (3) the focus on copulatory (consummatory)
behaviorsinanimalmodelsratherthanmatepreference(appetitive)
behaviors.Additionally, studies inhumansaregenerally limitedor
complicatedbysmallsamplesize; inadequateor inappropriate
matches or‘‘control’’groups; insufficient assessment of sexual ori-
entationorhormoneexposure;mixedhormonalexposures; exoge-
nous exposure to synthetic rather than naturally occurring hor-
mones;alterationsofgenitalanatomyrelatedtohormoneexposure;
confoundswithothermetabolic andphysical correlates of intersex
conditions; and/or simultaneousexposures toother treatmentcom-
pounds.Nonetheless, there is substantial evidence that early expo-
suretosexhormonesinfluencesanatomical,physiological,and
sexually dimorphic behavioral development in animals and
humans(Cohen-Bendahanetal.,2005;Reinisch,1974;Reinisch&
Sanders, 1984, 1987; Reinisch et al., 1991). Thus, investigation of
theroleofprenatalsexhormonesinthedevelopmentofhumansex-
ual orientation incorporatingmore effective controls is warranted.
Ithasbeensuggestedthat thepotential roleofprogesterone in
mammalian sexual differentiation and development has been
insufficiently investigated (Dodd, Jones, Flenady, Cincotta, &
Crowther, 2013; Wagner, 2008). Although androgenic, estro-
genic, and antiandrogenic compounds have received attention
(includingsyntheticprogestins, someofwhichhaveandrogenic
effects), therehasbeenrelatively littleexaminationof the roleof
progesterone, despite its demonstrated antiandrogenic and antie-
strogenic effects on some systems (Dorfman, 1967; Sanders &
Reinisch,1985).Progesteroneandsyntheticprogestinsarecom-
monly prescribed during early pregnancy for luteal phase sup-
port during in vitro fertilization and for threatened abortion
(Aboulghar,2009;Bakeret al., 2014,Palagianoetal., 2004)and
later in pregnancy for prevention of premature birth and low
birth weight (da Fonseca, Bittar, Damião, & Zugaib, 2009).
Few studies have examined the long-term physical and
behavioral outcomes of either naturally occurring or synthetic
progestin exposure in humans (Cohen-Bendahan et al., 2005;
Hartwig et al., 2014; Hines, 2004, 2010; Northen et al., 2007;
Reinisch,1974,Reinisch&Sanders,1984,1987;Reinischetal.,
1991). Maternal intake of synthetic progestins and/or proges-
terone during pregnancy has been found to be associated with
increased hypospadias (urinary opening on the underside of the
penis instead of the tip) risk in males (Carmichael et al., 2005;
Dorfman, 1967; Silver, Rodriguez, Chang, & Gearhart, 1999)
and alteration of some sex-differentiated behavior patterns in
male and female offspring (Cohen-Bendahan et al., 2005; Ehr-
hardt, Grisanti, & Meyer-Bahlburg, 1977; Kester et al., 1980;
Reinisch, 1974, 1977, 1981;Reinisch&Karow,1977;Reinisch
& Sanders, 1984, 1987; Reinisch et al., 1991; Sanders & Rein-
isch, 1985).
One of these studies examined the effects of ‘‘natural’’ pro-
gesterone on sex/gender development (Kester et al., 1980). It
included 10 men (19–24years) exposed prenatally to natural
progesteronealoneandacontrolgroupmatchedondateofbirth,
age of mother, and, in most cases, prior numbers of siblings.
Progesterone-exposed subjects‘‘tended to recall boyhood behav-
iors which departed from the conventional male mode toward
‘femininity’’’and those subjects exposed to higher doses scored
loweron theBemSex-Role InventoryMasculine scale and lower
on the Feminine scale. A more recent study of fetal exposure to
prescriptiondrugsand sexualorientationdidnotfindasignificant
relationship between maternal reports of progesterone/progestin
exposure and sexual orientation, but the study was limited by its
1240 Arch Sex Behav (2017) 46:1239–1249
123
reliance on maternal recall of medical treatment often decades
earlier, among other methodological issues (Ellis & Hellberg,
2005).
Inlightofthesefindingsandthedearthofdataontheoffspring
of progesterone-treated pregnancies,we compared data on sex-
ual orientation and attraction from young adults who were
exposed in utero to progesterone (bioidentical progesterone=
C21H30O2;MW: 314.46) viamaternalmedical treatment to data
fromunexposedmatched controls.The study employeda case–
control, double-blind, prospective, longitudinal design using
membersofabirthcohortwithmatchingofcasesandcontrolson
14 physical, medical, and socioeconomic variables that were
recorded prenatally or at birth; careful evaluation of prenatal
hormone exposure; and assessment of sexual orientation and
attraction. Based upon the limited animalmodels and human
research, we hypothesized that progesterone-exposed human
offspring would show more same-sex attraction and behavior
with more exposed subjects identifying as non-heterosexual.
Method
Participants
Data from 34 subjects (17men and 17women) prenatally ex-
posed exclusively to lutocyclin and no other hormonal prepa-
ration, and their individuallymatched unexposed controlswere
drawn from an existing database, the US/Denmark Prenatal
Development Project (PDP) (Reinisch, Mortensen, & Sanders,
1993). Lutocyclin is identified as progesterone (bioidentical pro-
gesterone=C21H30O2; MW: 314.46) in the Danish Physician’s
Desk Reference (Junager & Schleisner, 1963) and was admin-
isteredduringpregnancy to treat cases of potentialmiscarriage as
indicated by staining or bleeding, abortion imminens (threatened
abortion), or maternal history of repeatedmiscarriage.Mean age
of the participants at the time of assessment for this study was
23.2years (SD=1.4).
Participants were drawn from the Copenhagen Perinatal
Cohort, comprising all 9125 offspring born at the University
Hospital in Copenhagen, Denmark, between 1959 and 1961.
During the establishment of the cohort, demographic, socioe-
conomic, and medical variables were prospectively recorded
pre-, peri-, and postnatally. Potential participants for the current
study were identified through the available computerized data-
base. Exclusion criteria were: offspring of incest; gestation
length less than 28weeks; congenital malformation (including
genital ambiguity); Down’s syndrome;maternal history of dia-
betes,epilepsyorCNSdisorder;maternaltreatmentwiththyroid
medication;maternalpsychosisorsyphilis;mother less thanage
16 at time of delivery; and mother diagnosed with polio,
encephalitis, meningitis, viral pneumonia, or ornithosis during
pregnancy. The original datatape only coded yes/no for drug
exposure in terms of the class of drug administered (hormone,
barbiturate, antiepileptic, etc.) for at least 5 days during each of
six gestational periods, coded into trimesters for these analyses.
Original hospital records for all hormone-exposed cases and
their matched controls were reviewed by our team to confirm
exclusion criteria and to obtain specific information on dosage,
timing, and duration of exposure to all gestational treatments.
All eligible cases were recruited to participate in the PDP. The
overallparticipationrateforthePDPwas87%.Extensivedetails
of the methodology are reported elsewhere (Reinisch et al.,
1993; Reinisch, Sanders, Mortensen, & Rubin, 1995). Partici-
pants only knew theywere recruited due to their inclusion in the
Danish Perinatal Cohort at birth butwere blind as to their expo-
sure status.
Of the45casesexposedto lutocyclininthePDPdatabase, the
34 included here were those exposed to lutocyclin and no other
hormonal preparation, so that anyobservedeffects of lutocyclin
would not be confounded by exposures to other hormones.
Matches were chosen from 271 non-exposed controls selected
from a large pool of similarly evaluated PDPmembers.
Matching occurred in two stages using 14 variables with
exact matching for sex. The objective of the matching was to
obtain a set of control subjectswhose distributions onmatching
variableswereascloseaspossibletothedistributionsofexposed
subjects. First, usingMahalanobismetricmatchingwithin cali-
pers defined by the estimatedpropensity score for each exposed
case, the 10 statistically best potential controls were identified
(Rosenbaum & Rubin, 1985a, 1985b) and then the Project
Director (J.M.R.)matched one or two potential controls to each
exposed case for inclusion in the study. Details of thematching
procedure have been published elsewhere (Reinisch et al.,
1993, 1995). Table 1 shows that therewere no significant group
differences (exposedvs. unexposed) in the distributions ofmat-
ching variables.
WhenthePerinatalCohortwasestablished,pregnantwomen
were interviewedas soonas theywere enrolled for prenatal care
about whether they were married or single, had planned the
pregnancy at the time of conception, or had attempted abortion
(Villumsen, 1970). For exposed cases, there was one single
mother (2.9%), one unplanned pregnancy (2.9%, not the same
person), and no abortion attempts. For the matched control
sample,23%ofthemothersweresingle,44%of thepregnancies
were unplanned, and 12% had attempted abortion. The per-
centagesfortheoverallcohortwere37,56,and7%,respectively.
It is not surprising that special treatment for pregnancy main-
tenancewas confoundedwith beingmarried, planning orwant-
ingthepregnancy,andnotattemptingabortion.Therefore, these
were not used asmatching variables.At the time, relatively few
coupleswere living togetherwithout beingmarried and being a
single mother may have presented difficulties. We do not
interpret thesepotentialconfoundsaspotentialcausativefactors
for same-sex (homosexual/bisexual) behavior and attraction. In
thePDPsampleofmorethan550participants, thesethreemater-
Arch Sex Behav (2017) 46:1239–1249 1241
123
nal variables were unrelated to offspring sexual orientation, at-
traction, or sexual behavior in either sex.
Lutocyclin exposure parameters in the present sample were
asfollows:Meantotaldosagewas915mg(SD=1073.54,range
40–5400mg)with amean treatment duration of 61days (SD=
42, range 8–158). Average daily dose was calculated for each
individualbydividingtotaldosagebydurationof treatment.The
group mean of‘‘average daily dose’’was 18.41mg/day. Forty-
onepercent(n=14)wereexposedduringthefirsttrimesteronly,
35%(n=12)during thefirstandsecondtrimesters,17%(n=6)
during the second trimester only, and 6% (n=2) during the
second and third trimesters. Table2 shows detailed informa-
tion on dosage and timing of exposure. Nominimum exposure
parameters were set for selection; thus, these represent the nor-
mal rangeofdosagesanddurationscommonlyusedin treatment
of at-risk pregnancy in Denmark during this period. Exposures
did not differ by sex. Timing of exposure occurred during peri-
odsassociatedwithsexualdifferentiationof theCNSinhumans.
Measures
Interview Data
Information on sexual orientation was obtained as part of a
structured interviewconductedbyapsychologist at the Institute
for Preventive Medicine in Copenhagen, Denmark. Psycholo-
gists were blind to the exposure status of all subjects. The fol-
lowing sexual orientation variables were addressed in the
comprehensive interview and coded as follows.
Same-Sex Variables
1. Self-labeled sexual orientation: (heterosexual/non-hetero-
sexual) [This item was drawn from a question asking par-
ticipants whether they considered themselves to be hetero-
sexual,homosexual,bisexual,‘‘don’tknow.’’Giventhesmall
numbers in the non-heterosexual categories, the data were
recoded to heterosexual/non-heterosexual for analysis.]
Table 1 Distributions of matching variables for prenatally progesterone-exposed and unexposed participants
Matching variable Exposed
n= 34
Unexposed
n= 34
Statistica p
%Maleb 50.0 50.0 na
% Firstborn 61.8 50.0 z= .85 ns
Mean (SD) gestation length (week) 37.76 (3.10) 38.12 (1.80) t(32)\1 ns Mean (SD) birth weight (g) 31.13 (8.85) 30.99 (5.06) t(33)\1 ns Mean (SD) birth length (cm) 50.97 (4.66) 50.69 (2.29) t(33)\1 ns Mean (SD) socioeconomic statusc 6.00 (1.55) 5.94 (1.52) t(31)\1 ns Mean (SD) breadwinner’s educationd 3.07 (.78) 3.06 (.74) t(29)\1 ns Mean (SD) mother’s age (year) 30.03 (4.46) 31.15 (5.76) t(33)=-1.06 ns
Mean (SD) father’s age (year) 35.00 (6.03) 33.48 (7.12) t(32)= 1.04 ns
Mean (SD) PBC 415e 33.85 (17.91) 33.53 (16.12) t(33)\1 ns Mean (SD) maternal complaint scoref 2.96 (2.48) 3.22 (2.52) t(33)\1 ns % Severe preeclampsia 3.0 2.9 z= 0 ns
%Maternal respiratory illness 2.9 2.9 z= 0 ns
Mean (SD) maternal weight gain (kg)/height cubed (m)Wgt/hght 25.52 (9.05) 25.29 (7.35) t(23)\1 ns Mean (SD) no. of cigarettes/day in third trimester 4.42 (7.01) 5.74 (7.64) t(32)\1 ns
a na=Not applicable. Unless otherwise noted df= 33 b Exact match required for sex c Family socioeconomicstatuswhen thechildwas1 yearofage.Danishsystemcategorizedonaneight-point scale, 1= lowest, 8= highest.Pairswere
exactly matched on SES, except for two exposed cases with missing data who were matched to controls with SES= 4 d Education was categorized on a four-point scale, 1= remedial instruction, 4= college e Thepredisposing riskscore is avariable in theoriginal cohortdatatape. It is ascorebasedonpregravidas factors concernedwith themother’sphysical
and emotional state prior to the pregnancy. Information includes such items aswhether themother wasmarriedwhen she conceived, whether she had
previously had an abortion, a miscarriage, a stillbirth, or neonatal death; her age; her weight; and previous history of central nervous system illness,
syphilis, cardiovascular illness, or diabetes. The score indicates that conditions (physical and emotional) were probably ‘‘less than optimum’’ for
conception at the time. For the cohort, the scores range from 0 to 130 and the mean is 29.52 f Thematernal complaint score included the following: severepreeclampsia, hypertension, prescriptionofdiuretics, edemaandproteinuria, bleeding/
staining, allergies and treatment with antihistamines, and anemia
1242 Arch Sex Behav (2017) 46:1239–1249
123
2. Lifetime attraction to own sex: (yes/no)
3. Current attraction to own or both sexes: (yes/no)
4. Kissed own sex: (yes/no)
5. Having been partially undressed in a sexual situationwith
own sex: (yes/no)
6. Havingbeen fullyundressed inasexual situationwithown
sex: (yes/no)
7. ‘‘Intercourse’’with own sex: (yes/no) [Our interview data
indicated that women generally interpreted this question
to mean mutual genital sexual stimulation; men usually
interpreted this as anal intercourse.]
Other-Sex Variables
8. Having kissed other (‘‘opposite’’) sex: (yes/no and age at
first engagement)
9. Having been partially undressed in a sexual situationwith
other sex: (yes/no and age at first engagement)
10. Having been fully undressed in a sexual situation with
other sex: (yes/no and age at first engagement)
11. Intercoursewith other sex: (yes/no, and age at first engage-
ment).
Items 4–11 were coded from questions asking age at first par-
ticipation in each behavior, an approach developed by Kin-
sey (Kinsey et al., 1948;Kinsey, Pomeroy,Martin,&Gebhard,
1953). Asking age at first engagement signals participants that
one is non-judgmental about their engagement in particular
sexualbehaviors.Apostpubertal criterionwasapplied forageat
first engagement in thesebehaviors. Specifically, age at puberty
(whichwasassessedbyaseparatesetofquestionsaboutmarkers
ofpuberty)wascomparedtothereportedageatfirstengagement
in the behaviors. The very few reports of behaviors prior to
puberty were not included in these analyses as they could have
been childhood sexual exploration. This criterion was consis-
tently applied across all subjects and for both same-sex and
other-sex behaviors. The number of participants engaged in the
same-sexbehaviorswasinsufficient toconductastatisticalanal-
ysisofagefor thosevariables.However,wewereable toanalyze
age at first engagement in the heterosexual behaviors.
Questionnaire Data
Sexual Behavior Inventory (SBI) This self-administered
questionnaire was created for the PDP (Reinisch et al., 1993)
to assess whether or not 67 different sexual behaviors have
been tried. Three items on the questionnaire were relevant to
sexual orientation: (1) to ‘‘go to bed with’’ a person of your
own sex (in Danish, this item is understood to mean inter-
course or mutual genital contact); (2) to masturbate in the
presence of another person(s) of the same sex; and (3) to
masturbate in the presence of another person(s) of the oppo-
site sex.
SexualAttitudesQuestionnaire (SAQ) This self-administered
questionnaire, created for the PDP (Reinisch et al., 1993),
includes 120 items from the original Eysenck Inventory of
Attitudes towardSex (Eysenck, 1976). Participants indicated
their agreement/disagreement on a three-point scale (yes, ?,
no; scored 2, 1, 0, respectively) with 179 statements about
various aspects of sexuality. There are two factors relevant to
sexual orientation: attraction tomales and attraction to females.
Each factor has six items and shows good internal consistency
(Cronbach’s alphas .88 for attraction tomales and .90 for attrac-
tion to females). Items for attraction to males and attraction to
femaleswereworded identically except for the sex of the object
of attraction. Questions (in Danish) were scattered throughout
the SAQ. The 12 questions about attraction to males/females
translated into English are as follows:
• IusuallytakealonglookwhenImeetanattractiveman/woman in the street.
• Male/female sexual organs are attractive. • I often have fantasies about male/female sex partners. • Now and then I think about sex when I am in an attractive man’s/woman’s company.
• I sometimes have fantasies about being with two or more men/women at the same time.
• I regularly meet men/women whom I find attractive.
Table 2 Descriptive statistics for progesterone exposure variables (n= 34)
Progesterone exposure variables N (%)
Timing of exposure (trimesters)
1st only 14 41.2
1st–2nd 12 35.3
2nd only 6 17.6
2nd–3rd 2 5.9
3rd only 0 0.0
Total dosage (mg)
40–300 11 32.4
301–999 14 41.2
1000–1999 5 14.7
2000–5400 4 11.8
Duration of exposure (days)
8–29 9 26.5
30–60 12 35.3
61–120 8 23.5
121–158 5 14.7
Average daily dosage (mg/day)
3–9 16 47.1
10–25 7 20.6
26–50 11 32.4
Arch Sex Behav (2017) 46:1239–1249 1243
123
Procedure
Thestudywasapprovedbytheappropriatereviewboardsforthe
protectionofhumansubjects inboth theU.S.andDenmark.The
data presented in this article assessing sexual orientation rep-
resent a subset of a large evaluation battery (Reinisch et al.,
1993).Thepurposeandproceduresfor thestudywereexplained
to participants, and informed consent was obtained. A psychol-
ogist supervised the collection of questionnaire data and con-
ducted the interview during a full day of evaluation at the Insti-
tute for PreventiveMedicine. Evaluators and participants were
blind regarding treatment status.
Data Analysis
We hypothesized that same-sex behavior and attraction would
be higher for the exposed compared to the unexposed partici-
pants. Data were first examined for interactions between sex of
participant and exposure to lutocyclin. Finding none, data from
men and women were then combined for statistical analysis of
exposure effects, with the exception of scores for attraction to
males and attraction to females as these are more easily under-
stoodwhen presented separately by sex. For dichotomous vari-
ables, Tango’s (1998) test of the differences in proportions in
matchedpairswas used.Unlike theMcNemar test, Tango’s test
accommodates292 tableswithoff-diagonal zerocells. For con-
tinuous variables, paired t tests were performed to compare data
from exposed and unexposed participants. Spearman’s rho was
used to evaluate the correlation between attraction to males and
attraction to females. Relationships between progesterone treat-
ment parameters and outcomes of interest were assessed by the
Kolmogorov–SmirnovZ testofequalityofdistributions.We
report p values for two-tailed tests, a conservative criterion
given our directional hypotheses which would justify use of
one-tailed tests.
Results
As shown in Table 3, compared to their matched controls,
exposedcasesshowedaconsistentpatternofhigherpercentages
of:
1. Self-labeled identification as other than heterosexual (i.e.,
homosexual, bisexual, or‘‘don’t know’’) (20.6% exposed,
0% controls, p\.01). Among the exposed men, one iden- tified as homosexual, two as bisexual, and two said‘‘don’t
know.’’Among exposed women, two identified as bisex-
ual. All other subjects, exposed and unexposed, self-iden-
tified as heterosexual;
2. ‘‘Ever Attracted to Own Sex’’ (29.4% exposed, 5.9%
controls, p= .02);
3. ‘‘Currently Attracted to Own or Both Sexes’’ (17.6% ex-
posed, 2.9% controls, p\.06); and 4. Various sexual behaviors with their own sex including
‘‘kissed own sex’’; partially and fully undressed in a sexual
situation; ‘‘intercourse’’; ‘‘gone to bed’’; and ‘‘masturbated
together’’ (range 14.7–24.2% exposed cases, 0–9.1% of
controls). In general, behavioral patternswere consistent for
individuals. For example, all those reporting ‘‘intercourse’’
with a person of the same sex also reported ‘‘going to bed’’
with; being fully and partly undressed in a sexual situation
with; and kissing someone of the same sex.
None of those who identified as other than heterosexual had
own sex attractions or engaged in these same-sex behaviors
were concordant with their matches.
Exposure status was not associated with heterosexual expe-
rience—all participants reported sexual behaviorwith the other
sex.Thesmallnumberofcaseswhoengagedinsame-sexsexual
behaviorsprecludedstatisticalanalysesof‘‘AgeatFirstEngage-
ment’’ in those behaviors, but this measure for heterosexual
behaviorsdidnotdifferaccordingtoexposurestatus(seeTable4).
For men, scores on the attraction to males scale were signif-
icantly higher for exposed cases compared to controls, paired
t(16)=2.76,p\.02, two-tailed, but scores did not differ for the attraction to females scale (see Table5). For women, scores on
attraction to females scale were not different between exposed
and unexposed cases, but there was a statistical trend toward
higher scores on the attraction to males scale for exposed
women,paired t(16)=1.92,p= .07, two-tailed.Thus,exposure
was positively associatedwith higher scores on the attraction to
males scale regardless of sex, total group ofmales, and females
combined paired t(33)=3.31, p\.01, two-tailed. Although a bipolarmodelof sexualorientation(Kinseyetal.,1948;Sanders
et al., 1990)would predict a strongnegative relationshipbetween
scale scores for attraction to males and attraction to females, this
was not the case (for men, Spearman’s rho=-.10; for women,
rho= .23; both ns).
In light of findings linking birth order and number of older
brothers to homosexual orientation among men (Blanchard &
Bogaert, 1996; Cantor, Blanchard, Paterson,&Bogaert, 2002),
this possible confound was examined. Neither birth order nor a
number of older brothers confound the current findings. Not
surprisinggiven thematching,birthorderdidnotdifferbetween
exposed and unexposed men (M=1.76, SD= .96) and the
numberwhohadolderbrotherswasthesamefortheexposedand
unexposed groups (n=5 for each group).
A systematic investigation of the relationship between pro-
gesterone treatment parameters (i.e., total dosage, averagedaily
dosage, timing,anddurationofprogesteroneexposure)andout-
comesof interestwasprecludedby thehighvariability inmater-
nal medical treatment and the intercorrelations among the var-
ious treatmentparameters.Nonetheless, it isnoteworthy that the
seven individualswho self-identified as other thanheterosexual
1244 Arch Sex Behav (2017) 46:1239–1249
123
wereexposed tohigher totaldosages (median=1000mg, range
450–5400mg)overlongerdurations(median=105days,range
20–120days) than thosewhoidentifiedasheterosexual (median
total dosage=500mg, range 40–2700mg, K–S Z=-2.28,
p= .02; median duration=47days, range 8–158days, K–S
Z=-2.24, p\.03).
Discussion
In summary,we observed consistent findings across samples of
menandwomenprenatally exposed to exogenousprogesterone
for a set of variables directly reflective of sexual orientation.
Relative to unexposed controls, prenatal exposure to proges-
terone was significantly associated with: (1) decreased likeli-
hood of self-identification as heterosexual; (2) increased like-
lihood of having engaged in same-sex sexual behaviors; (3)
increased likelihood of reporting attraction to the same or both
sexes,and(4)higherscoresontheattractiontomalesscale.Pro-
gesterone exposurewas not associatedwith a decrease inmea-
sured heterosexual behavior.Amongprogesterone-exposed cases,
non-heterosexual identity was shown to be associated with higher
total dosages and longer duration of prenatal exposure to proges-
terone.
We recognize thatmany factorsmay affect the development
of sexual orientation and that the prenatal hormone environ-
ment is only one of these. In considering the epigenetic mech-
anism(s) bywhich prenatal exposure to exogenous progesterone
may influence sexual orientation, it is relevant that progesterone
appears to have both antiandrogenic and antiestrogenic potential
duringearlycriticalorsensitiveperiodsofdevelopment(Connolly,
Handa,&Resko,1988;Dorfman,1967;Kesteretal.,1980;Sanders
Table 3 Comparison of sexual orientation, attraction, and behavior variables for prenatally progesterone-exposed (Exp) and unexposed (Un) participants
Men
(17 pairs)
Women
(17 pairs)
Total group
(34 pairs)
z Statistica p (two-tailed)b
Exp Un Exp Un Exp Un
n n n n n (%) n (%)
Same sex
Non-heterosexual self-labeled identityc,d,e 5 0 2 0 7 20.6 0 0 2.56 .008
Ever attracted to own sexc 6 0 4 2 10 29.4 2 5.9 2.31 .021
Current attraction to own or both sexesc,e 3 0 3 1 6 17.6 1 2.9 1.88 .059b
Kissed own sexc,e 3 0 4 1 7 20.6 1 2.9 2.12 .034
Has been partially undressed in a sexual situation with own sexc,e,f 3 0 4 1 7 20.6 1 2.9 2.12 .034
Has been fully undressed in a sexual situation with own sexc,e,f 2 0 4 1 6 17.6 1 2.9 1.88 .059b
‘‘Intercourse’’with own sexc,e,f 2 0 3 0 5 14.7 0 0 2.23 .025
‘‘Gone to bed’’with person of own sexe,f,g 2 0 4 1 6 17.6 1 2.9 1.89 .059b
Masturbated in the presence of same sexg 6 2 2 1 8 24.2 3 9.1 1.67 .095b
Other (‘‘opposite’’) sex
Kissed other sexc 17 17 17 17 34 100 34 100 na na
Has been partially undressed in a sexual situation with other sexc 17 17 17 17 34 100 34 100 na na
Has been fully undressed in a sexual situation with other sexc 17 17 17 17 34 100 34 100 na na
Intercourse with other sexc,h 16 17 17 17 33 97.1 34 100 1.00 ns
Masturbated in the presence of other sexg 6 8 4 6 10 30.3 14 42.4 1.15 ns
a Tango’s (1998) test of the differences in proportions in the pair-sample design was used (na = Not applicable) b We have used a conservative criterion for statistical significance. The hypotheses are directional, and therefore, one-tailed tests may be justified. If
one-tailed tests are used, all same-sex variables in this table would be significant at p\.05 (na = Not applicable) c From the interview d Self-identification as lesbian, homosexual, bisexual, or‘‘don’t know’’was recoded as non-heterosexual. Specifically, among the exposed men one
identified as homosexual, two as bisexual, and two said‘‘don’t know.’’Among exposedwomen, two identified as bisexual. All other subjects, exposed
and unexposed, self-identified as heterosexual e Noneof thosewho identifiedasother thanheterosexual; hadownsexattractions; or engaged in these same-sexbehaviors,were concordantwith their
matches f In general, behavioral patterns were consistent for individuals. For example, all those reporting ‘‘intercourse’’with a person of the same sex, also
reported‘‘going to bed’’with, being fully and partly undressed in a sexual situation with, and kissing someone of the same sex g From the Sexual Behavior Inventory h Only one participant, a lutocyclin-exposed man (who reported same-sex‘‘intercourse’’), did not report having had heterosexual intercourse
Arch Sex Behav (2017) 46:1239–1249 1245
123
& Reinisch, 1985). Exogenous progesterone has been demon-
strated to have physiological effects during gestation despite the
presenceofhighendogenous levels (Aboulghar, 2009; daFonseca
et al., 2009; Palagiano et al., 2004; Silver et al., 1999). Exogenous
progesterone administrated in associationwith invitro fertilization
hasbeen suggested as a factor in increased rates of hypospadias in
malenewborns (Carmichael et al., 2005;Dorfman,1967;Silver
et al., 1999). Additionally, emerging researchwith rodents sug-
gests progesterone andprogesterone receptorsmayplay an impor-
tant role in thedevelopmentofdimorphic sexual, cognitive, social,
and affective behavior differentiation (Wagner, 2008; Wagner,
Nakayama, & De Vries, 1998). While the direct physiological
mediators of the effects of prenatal progesterone exposure await
identification,ourfindingsmaybeconsideredabehavioralbioas-
say of such underlying effects (Reinisch, 1974; Reinisch et al.,
1991). This bioassay makes it clear that exposure to exogenous
progesterone during a sensitive period of humanCNS differenti-
ationmaypermanentlyaffectneuralfunctionandultimatelyinflu-
ence later behavior. It is also possible thatmedical treatmentwith
progesterone isamarkerofmaternalprogesteronedeficiencyand
thatvariation inendogenousmaternalprogesterone levelsmaybe
animportantfactorinnaturallyoccurringdifferencesinsexualori-
entation. The detection of a relationship between prenatal expo-
sure to exogenous progesterone and sexual orientation in early
adulthood,despitemanyinterveningfactors,supports thehypoth-
esis that the prenatal hormone environment is influential.
Howmight the addition of exogenousprogesterone into an
already rich mixture of gestational steroids, including endoge-
nous progesterone, affect the nervous system and subsequent
behavioral development of the offspring? First, in keepingwith
themostcurrentclinicalresearch,thishormonalmedicationwas,
and continues to be, administered by physicians to treat symp-
tomsof staining,bleeding, topreventprematurity in twins (Rouse
etal.,2007;Schuitetal.,2015),andtopreventpretermbirth(Dodd
et al., 2013; Merlob, Stahl, & Klinger, 2012) and for imminent
spontaneousabortion(daFonsecaetal.,2009).Thisdemonstrates
its capacity to have some meaningful physiological impact. It is
currentlyusedforpain,uterinecontractions,andinadequateluteal
phase, and its effectiveness has been demonstrated on both ultra-
sound assessment of uterine contraction and a pain scale (Pala-
gianoetal.,2004).Second,progesteronewasadministeredexoge-
nously at pharmacological levels during periods of gestation
known to be sensitive to the influence of steroid hormones on
sexualdevelopment(seeTable2).Third,exogenouslyintroduced
hormonesmaydiffer from (and thus have different potency than)
their endogenous counterparts in how they aremetabolized, their
receptor affinity and sensitivity, and their systemic versus local-
ized action. Thus, it is possible that, compared to endogenous
levels, even relatively limited physiological dosesmay have sig-
nificant effects on various systems when administered exoge-
nously.
Table 4 Comparison of ages of first engagement in sexual behaviors with other sex for prenatally progesterone-exposed and unexposed participants (34 pairs)
Other-sex variable Exposed Unexposed Paired t p
M (SD) M (SD)
Age at first kissing other sex (years) 13.81 (2.77) 13.10 (.40) 1.21 ns
Age at first being partially undressed in a sexual situation with other sex (years) 14.82 (2.43) 14.10 (2.60) 1.33 ns
Age at first being fully undressed in a sexual situation with other sex (years) 15.72 (2.50) 14.97 (2.43) 1.35 ns
Age at first intercourse with other sex (years) 16.39 (2.29) 15.81 (2.75) 1.02 ns
Table 5 Comparison of scores for attraction to males and attraction to females for prenatally progesterone-exposed (Exp) and unexposed (Un) participants within sex
Score Males (17 pairs) Females (17 pairs)
Exp Un Paired t p (two-tailed) Exp Un Paired t p (two-tailed)
Attraction to males
M .52 .13 2.76 .014 1.57 1.40 1.92 .073
SD .56 .18 .29 .48
Attraction to females
M 1.76 1.81 \1 ns .75 .58 \1 ns SD .43 .23 .54 .51
Possible scores ranged from 0 to 2
1246 Arch Sex Behav (2017) 46:1239–1249
123
A limitation common to studies of sexuality is their reliance
on self-report. The non-normative status of same-sex attraction
andbehavior tends toproduce a social desirability effect toward
underreporting these behaviors. Any such bias would have
servedtominimizedifferencesbetweengroups.Similarly,small
sample size often results in limited statistical power. It is also
important to note that in research on human prenatal exposures,
our34caseswithasingleunconfoundedtypeofhormonalexpo-
sure represent an unusually large number. More detailed eval-
uationsoftreatmentparameterswerenotpossiblegiventhewide
range of individual treatment regimes and the colinearity of the
treatmentvariables.Despitethevariationintreatmentregimens,
theextensivecomparableprospectivedataavailableonbothindex
cases and controls provide confidence in the treatment status for
bothgroupsanda relatively largepoolofmatchingvariables.Our
groups were carefully matched on 14 highly relevant prenatal,
perinatal, and maternal factors which should serve to minimize
confounds incomparisonsbetweenexposedandcontrol subjects.
It shouldbe taken intoaccount thatparticipantswere in their early
to mid-20s when evaluated and that the lifetime range of their
patterns of sexual behavior and attractionswas not likely to have
been fully realized by early adulthood. Follow-up studies would
be required to evaluate the levels of same-sex behavior and/or
attraction thatmay have been revealed in subsequent decades. In
keeping with the strengths of the current design, we found con-
sistent statistically significant effects across a number of different
measures supporting our hypotheses.
What are the theoretical implications of our findings regard-
ing the conceptualizationof the nature of sexual orientation and
its biological bases?Support for the commonlyheldbipolarmodel
of sexual orientation (a unidimensional model where one pole
representshomosexualityand theother, heterosexualityormas-
culinity vs. femininity; Kinsey et al., 1948) requires a strong
negative correlation between scale scores on attraction tomales
and attraction to females (Sanders et al., 1990) as well as that
betweensameandopposite sexexperience.However, our study
fails to support thismodel since inbothmales and females these
correlationswerelowandnotsignificant.Therefore,wehypoth-
esize that sexual orientation may be more accurately and pro-
ductively conceptualized in terms of a two-dimensional model
in which the dimensions of heterosexuality and homosexuality
are relatively independent, with each dimension having a high
and low pole, perhaps reflecting different neurodevelopmental
pathways (Olvera-Hernandez, Chavira, & Fernandez-Guasti,
2015;Sandersetal.,1990;Storms,1988).Suchaperspectivefits
well with similar models we have described for the differentia-
tion of masculinity and femininity in the context of the devel-
opment of more general aspects of gender identity and role
(Reinisch & Sanders, 1987; Reinisch et al., 1991). Method-
ologically, our results emphasize that studies of sexual
expression,whichfocusonsame-sexor‘‘opposite’’-sexbehavior
to the exclusion of the other, may obscure the prevalence of
bisexual patterns.
In conclusion, these findings reveal that prenatal progester-
onehasbeenanunderappreciatedfactor inhumanpsychosexual
development (as are the actions of fetal testosterone or extern-
ally introduced endocrine disruptors). Our findings suggest
that natural perturbations in endogenous progesterone dur-
inggestationmayaffect individual differences in the expres-
sionofadultsexualorientation.Specifically,progesteroneexpo-
surewas found to be related to increased non-heterosexual self-
identification,attraction to thesameorbothsexes,andsame-sex
sexual behavior. The findings challenge the prevailing view of
homosexual interest andbehaviorasa simple reflectionof femi-
nization/demasculinization in males and masculinization/de-
feminizationinfemales.Incontrast,thecurrentresearchunderli-
nes thenecessityofconcurrentmeasurementofawidespectrum
of both same-sex and‘‘opposite’’-sex behaviors and attitudes in
any study of human sexual expression.
The current findings highlight the likelihood that prenatal
exposuretoprogesteronemayhavelong-termbehavioralseque-
lae related to sexuality in humans, even in the absence of mor-
phologicaleffectsonthegenitalia. Inlightof thecontinuedtreat-
ment of human pregnancies with progesterone (and other pro-
gestogens), further studies of offspring of progesterone-treated
pregnancies are warranted and may provide important insights
into the role of this hormone in human behavioral development
(Dodd et al., 2013).
Acknowledgements WethankLeonardA.Rosenblum for editingof the article, CarolynS.Kaufman for research assistanceduringdata collection
and archiving, and Brandon Hill for assistance with literature searches.
Funding This research was supported in part by US Public Health Ser- viceGrantsDA05056toJMRandSAS,GrantsHD17655andHD20263to
JMR, Grant 9700093 from the Danish Research Councils to ELM. Some
preliminary analyses of a portion of the complete data presented in final
form in this paper were previously described in a thesis by Caroline Ripa,
University of Copenhagen, 2002.
Compliance with Ethical Standards
Conflict of interest The authors declare that they have no conflict of interest.
Ethical Approval Existing data from human research participants were used. All procedures performed in studies involving human participants
were in accordance with the ethical standards of the institutional and/or
national researchcommitteeandwith the1964HelsinkiDeclarationand its
later amendments or comparable ethical standards.
Informed Consent At the time of data collection, informed consent was obtained from all individual participants included in the study.
Arch Sex Behav (2017) 46:1239–1249 1247
123
References
Aboulghar,M.(2009).Luteal support in reproduction:When,whatandhow?
Current Opinion in Obstetrics and Gynecology, 21, 279–284.
Adkins-Regan, E. (1988). Sex hormones and sexual orientation in animals.
Psychobiology, 16, 335–347.
Baker,V.L., Jones,C.A.,Doody,K., Foulk,R.,Yee,B.,Adamson,G.D.,… Soules, M. (2014). A randomized, controlled trial comparing the effi-
cacyandsafetyofaqueoussubcutaneousprogesteronewithvaginalpro-
gesterone for luteal phase support of in vitro fertilization. Human
Reproduction, 29, 2212–2220.
Balthazart, J. (2011).Minireview: Hormones and human sexual orientation.
Endocrinology, 152, 2937–2947.
Blanchard,R.,&Bogaert,A.F.(1996).Homosexualityinmenandnumberof
older brothers. American Journal of Psychiatry, 153, 27–31.
Cantor, J.M., Blanchard, R., Paterson, A. D., &Bogaert, A. F. (2002). How
many gay men owe their sexual orientation to fraternal birth order?
Archives of Sexual Behavior, 31, 63–71.
Carmichael,S.L.,Shaw,G.M.,Laurent,C.,Croughan,M.S.,Olney,R.S.,&
Lammer, E. J. (2005). Maternal progestin intake and risk of hypospa-
dias. Archives of Pediatric and Adolescent Medicine, 159, 957–962.
Cohen-Bendahan,C., van deBeek, C.,&Berenbaum, S.A. (2005). Prenatal
sex hormone effects on child and adult sex-typed behavior: Methods
and findings.Neuroscience and Biobehavioral Reviews, 29, 353–384.
Connolly,P.B.,Handa,R.J.,&Resko,J.A.(1988).Progesteronemodulation
of androgen receptors in thebrainandpituitaryofmaleguineapigs.En-
docrinology, 122, 2547–2553.
daFonseca,E.B.,Bittar,R.E.,Damião,R.,&Zugaib,M.(2009).Prematurity
prevention:Theroleofprogesterone.CurrentOpinioninObstetricsand
Gynecology, 21, 142–147.
Dodd, J. M., Jones, L., Flenady, V., Cincotta, R., & Crowther, C. A. (2013).
Prenatal administration of progesterone for preventing preterm birth in
women considered to be at risk of preterm birth. Cochrane Database
Systematic Review, 7,Article No. CD004947.
Dorfman,R. I. (1967). Invitrofertilizationisassociatedwithanincreasedrisk
of hypospadias. Anatomical Record, 57, 547–557.
Ehrhardt,A.A.,Grisanti,G.C.,&Meyer-Bahlburg,H.F.L. (1977).Prenatal
exposure to medroxyprogesterone acetate (MPA) in girls. Psychoneu-
roendocrinology, 2, 391–398.
Ellis, L., & Ames, M. A. (1987). Neurohormonal functioning and sexual
orientation:A theory of homosexuality-heterosexuality.Psychological
Bulletin, 101, 233–258.
Ellis,L.,&Hellberg, J. (2005).Fetal exposure toprescriptiondrugs andadult
sexual orientation. Personality and Individual Differences, 39, 225–
236.
Eysenck, H. J. (1976). Sex and personality. Austin, TX:University of Texas
Press.
Gooren,L. (2006).Thebiologyofhumanpsychosexual differentiation.Hor-
mones and Behavior, 50, 589–601.
Grimbos, T., Dawood, K., Burris, R., Zucker, K. J., & Puts, D. A. (2010).
Sexual orientation and the second to fourth finger length ratio: Ameta-
analysis in men and women. Behavioral Neuroscience, 124, 278–287.
Hartwig, I.R.,Bruenahl,C.A.,Ramesch,K.,Keil,T., Inman,M.,Arck,P.C.,
& Pincus, M. (2014). Reduced levels of maternal progesterone during
pregnancy increase the risk for allergic airwaydiseases in femalesonly.
Journal of Molecular Medicine, 92, 1093–1104.
Hines,M.(2004).Psychosexualdevelopmentinindividualswhohavefemale
pseudohermaphroditism. Child and Adolescent Psychiatric Clinics of
North America, 13, 641–656.
Hines, M. (2010). Sex-related variation in human behavior and the brain.
Trends in Cognitive Science, 14, 448–456.
Hines,M. (2011). Prenatal endocrine influences on sexual orientation andon
sexually differentiated childhood behavior. Frontiers in Neuroen-
docrinology, 32, 170–182. doi:10.1016/j.yfrne.2011.02.006.
Hines, M., Constantinescu, M., & Spencer, D. (2015). Early androgen
exposure and human gender development. Biology of Sex Differ-
ences, 6. doi:10.1186/s13293-015-0022-1.
Hiraichi, K., Sasaki, S., Shikishima, C., & Ando, J. (2012). The second to
fourth digit ratio (2D:4D) in a Japanese twin sample: Heritability, pre-
natal hormone transfer, and associationwith sexual orientation.Archives
of Sexual Behavior, 41, 711–724.
Jordan-Young, R. M. (2012). Hormones, context, and ‘‘brain gender’’: A
reviewofevidence fromcongenital adrenalhyperplasia.SocialScience
andMedicine, 74, 1738–1744.
Junager, S. A.,& Schleisner, A. H. (1963). Lægeforeningensmedicinforteg-
nelse [Danish Physician’s Desk Reference]. Copenhagen: Læge-
foreningens Forlag.
Kester, P., Green, R., Finch, S. J., & Williams, K. (1980). Prenatal ‘female
hormone’ administration and psychosexual development in human
males. Psychoneuroendocrinology, 5, 269–285.
Kinsey,A.C.,Pomeroy,W.B.,&Martin,C.E.(1948).Sexualbehaviorinthe
human male. Philadelphia, PA:W. B. Saunders.
Kinsey,A.C.,Pomeroy,W.B.,Martin,C.E.,&Gebhard,P.H. (1953).Sexual
behavior in the human female. Philadelphia, PA:W. B. Saunders.
Merlob,P.,Stahl,B.,&Klinger,G. (2012).17a-hydroxyprogesteronecaproate
for prevention of recurrent spontaneous preterm birth. Reproductive
Toxicology, 33, 15–19.
Meyer-Bahlburg, H. F. L. (1984). Psychoendocrine research on sexual orien-
tation:Current status and futureoptions.Progress inBrainResearch, 61,
375–398.
Meyer-Bahlburg, H. F. L., Ehrhardt, A. A., Rosen, L. R., Gruen, R. S.,
Verdiano, N. P., Vann, F. H., & Neuwalder, H. F. (1995). Prenatal
estrogens and the development of homosexual orientation. Develop-
mental Psychology, 31, 12–21.
Northen, A. T., Norman, G. S., Anderson, K., Moseley, L., Divito, M.,
Cotroneo, M., … Anderson, G. D. (2007). Follow-up of children exposed in utero to 17a-hydroxyprogesterone caproate comparedwith placebo.Obstetrics and Gynecology, 110, 865–872.
Olvera-Hernandez, S., Chavira,R.,&Fernandez-Guasti,A. (2015). Prenatal
letrozole produces a subpopulation of male rats with same sex-prefer-
ence and arousal as well as female sexual behavior. Physiology and
Behavior, 139, 403–411.
Palagiano,A.,Bulletti,C.,Pace,M.C.,DeZiegler,D.,Cicinelli,E.,&Izzo,A.
(2004).Effectsofvaginalprogesteroneonpainanduterinecontractility
in patientswith threatened abortion before twelveweeks of pregnancy.
Annals New York Academy of Sciences, 1034, 200–210.
Reinisch, J.M. (1974).Fetalhormones, thebrain, andhumansexdifferences:
Aheuristic, integrativereviewoftherecentliterature.ArchivesofSexual
Behavior, 3, 51–90.
Reinisch, J. M. (1977). Prenatal exposure of human foetuses to synthetic
progestin and oestrogen affects personality.Nature, 266, 561–562.
Reinisch, J. M. (1981). Prenatal exposure to synthetic progestins increases
potential for aggression in humans. Science, 211, 1171–1173.
Reinisch, J. M., & Karow, W. G. (1977). Prenatal exposure to synthetic
progestins and estrogens: Effects on human development. Archives of
Sexual Behavior, 6, 257–288.
Reinisch, J. M., Mortensen, E. L., & Sanders, S. A. (1993). The Prenatal
Development Project. Acta Psychiatrica Scandinavica Supplement,
370, 54–61.
Reinisch,J.M.,&Sanders,S.A.(1984).Prenatalgonadalsteroidal influences
on gender-related behavior.Progress in Brain Research, 61, 407–416.
Reinisch, J. M., & Sanders, S. A. (1987). Behavioral influences of prenatal
hormones. InC.B.Nemeroff&P.T. Loosen (Eds.),Handbook of clin-
ical psychoneuroendocrinology (pp. 431–448). New York, NY: Guil-
ford Press.
Reinisch, J. M., Sanders, S. A., Mortensen, E. L., & Rubin, D. B. (1995). In
uteroexposure tophenobarbital and intelligencedeficits inadulthuman
males. Journal of theAmericanMedical Association, 274, 1518–1524.
1248 Arch Sex Behav (2017) 46:1239–1249
123
Reinisch, J. M., Ziemba-Davis, M., & Sanders, S. A. (1991). Hormonal
contributionstosexuallydimorphicbehavioraldevelopmentinhumans.
Psychoneuroendocrinology, 16, 213–278.
Rosenbaum,P.R.,&Rubin,D.B.(1985a).Thebiasduetoincompletematch-
ing. Biometrics, 41, 103–116.
Rosenbaum, P. R., & Rubin, D. B. (1985b). Constructing a control group
using multivariate matched sampling methods that incorporate the
propensity score. The American Statistican, 39, 33–38.
Rouse, D. J., Caritis, S. N., Peaceman, A. M., Sciscione, A., Thom, E. A.,
Spong, C. Y.,… Anderson, G. (2007). A trial of 17a-hydroxyproges- teroneCaproate topreventprematurity inTwins.NewEnglandJournal
of Medicine, 357, 454–461.
Sanders, S. A., & Reinisch, J. M. (1985). Behavioral effects on humans
of progesterone-related compounds during development and in the
adult. In D. Ganten & D. Pfaff (Eds.), Current topics neuroen-
docrinology (Vol. 5): Actions of progesterone on the brain (pp.
175–205). Heidelberg: Springer.
Sanders, S. A., Reinisch, J.M.,&McWhirter, D. P. (1990). Homosexuality/
heterosexuality: An overview. In D. P.McWhirter, S. A. Sanders, & J.
M.Reinisch(Eds.),Homosexuality/heterosexuality:Conceptsofsexual
orientation (pp. 10–12). NewYork, NY: Oxford University Press.
Schuit, E., Stock, S., Rode, L.,Rouse,D. J., Lim,A.C.,Norman, J. E.,… Mol, B. W. (2015). Effectiveness of progestogens to improve
perinatal outcome in twin pregnancies: An individual participant
data meta-analysis. British Journal of Gynecology, 122, 27–37.
Silver, R. I., Rodriguez, R., Chang, T. S., & Gearhart, J. P. (1999). In vitro
fertilization is associatedwithan increased riskofhypospadias.Journal
of Urology, 161, 1954–1957.
Storms,M.D. (1988). Theories of sexual orientation. Journal of Personality
and Social Psychology, 38, 783–792.
Tango, T. (1998). Equivalence test and confidence interval for the difference
in proportions for the paired-sample design. Statistics in Medicine, 17,
891–908.
Valla,J.,&Ceci,S.J. (2011).Cansexdifferencesinsciencebetiedtothelong
reach of prenatal hormones? Brain organization theory, digit ratio
(2D:4D), and sex difference in preferences and cognition.Perspectives
in Psychological Science, 6, 134–136.
Villumsen, A. L. (1970). Environmental factors in congenital malforma-
tions:Aprospective studyof9006humanpregnancies.Copenhagen:
F.A.D.L.S. Forlag.
Wagner, C. K. (2008). Minireview: Progesterone receptors and neural
development: A gap between bench and bedside? Endocrinology,
149, 2743–2749.
Wagner, C. K., Nakayama, A. Y., & De Vries, G. J. (1998). Potential role of
maternalprogesteroneinthesexualdifferentiationofthebrain.Endocrinol-
ogy, 139, 3658–3661.
Wong,W.I.,&Hines,M. (2015). Interpretingdigit ratio (2D:4D)—behavior
correlations: 2D:4D sex difference, stability, and behavioral correlates
and their replicability in young children.Hormones and Behavior, 78,
86–94.
Arch Sex Behav (2017) 46:1239–1249 1249
123
Archives of Sexual Behavior is a copyright of Springer, 2017. All Rights Reserved.
- Prenatal Exposure to Progesterone Affects Sexual Orientation in Humans
- Abstract
- Introduction
- Method
- Participants
- Measures
- Interview Data
- Same-Sex Variables
- Other-Sex Variables
- Questionnaire Data
- Sexual Behavior Inventory (SBI)
- Sexual Attitudes Questionnaire (SAQ)
- Procedure
- Data Analysis
- Results
- Discussion
- Acknowledgements
- References

Get help from top-rated tutors in any subject.
Efficiently complete your homework and academic assignments by getting help from the experts at homeworkarchive.com